- Guo, Z, S Vangapandu, R W Sindelar, L A Walker and R D Sindelar. 'Biologically active quassinoids and their chemistry: potential leads for drug design'. Frontiers in Medicinal Chemistry. 4 (2009): in press.
- Armstrong, PW, LJ Dempster, DG Hawkins, M law, TH Ogilvie, C Orchard, MT Schechter, RD Sindelar, CI Whiteside. 'The birth of the Canadian Academy of Health Sciences’. Clinical Investigation of Medicine. 28.2 (2005): 43 – 45.
- Guo, Z, S Vangapandu, A Nimrod, LA Walker and R D Sindelar. 'Synthesis of A/B-ring partial analogs of bruceantin as potential antimalarial agents'. Medicinal Chemistry. 1.1 (2005): 3 – 11.
- Guo, Z, S Vangapandu, R W Sindelar, L A Walker and R D Sindelar. 'Biologically active quassinoids and their chemistry: potential leads for drug design'. Current Medicinal Chemistry. 12.2 (2005): 173 - 190.
- Bradbury, Barton J, Piotr Bartyzel, Teodoro S Kaufman, Marcelo J Nieto, Robert D Sindelar, Susanne M Scesney, Bruce R Gaumond and Henry C Marsh. 'Synthesis and complement inhibitory activity of B/C/D-ring analogues of the fungal metabolite 6,7-diformyl-3',4',4a',5',6',7',8',8a'-octahydro-4,6',7'-trihydroxy- 2',5',5',8a'-tetramethylspiro[1'(2'H)-naphthalene-2(3H)-benzofuran].'. Medicinal Chemistry. 46.13 (2003): 2697 - 2705.
- Bradbury, BJ, P Bartyzel, T S Kaufman, M J Nieto, R D Sindelar, S M Scesney, BR Gaumond and H C Marsh. 'Synthesis and complement inhibitory activity of B/C/D-ring analogues of the fungal metabolite 6,7-diformyl-3',4',4a',5',6',7',8',8a'-octahydro-4,6',7'-trihydroxy- 2',5',5',8a'-tetramethylspiro[1'(2'H)-naphthalene-2(3H)-benzofuran]'. Medicinal Chemistry. 46.13 (2003): 2697 - 2705.
- Muri, EM, MJ Nieto, R D Sindelar and J S Williamson. 'Hydroxamic acids as pharmacological agents'. Current Medicinal Chemistry. 9.17 (2002): 1631 - 1653.
- Assefa, H, A Nimrod, L Walker and R Sindelar. 'Enantioselective synthesis and complement inhibitory assay of A/B-ring partial analogues of oleanolic acid.'. Bioorganic & Medicinal Chemistry letters. 11.13 (Jul 9, 2001): 1619 - 1623.
Books:
- Crommelin, DJA, Meibohm, B and R D Sindelar, ed. Pharmaceutical biotechnology, An Introduction for Pharmacists and Pharmaceutical Scientists. 3rd. New York: Informa Healthcare Publishers, 2007.
- Crommelin, DJA, Meibohm, B and R D Sindelar, ed. Pharmaceutical biotechnology, An Introduction for Pharmacists and Pharmaceutical Scientists. Textbook Edition. New York: Informa Healthcare Publishers, 2007.
- Sindelar, R D. Chapter 7: Genomics, Proteomics, and Additional Biotechnology-Related Techniques'. Pharmaceutical Biotechnology, An Introduction for Pharmacists and Pharmaceutical Scientists. Ed. DJA Crommelin, B Meibohm and R D Sindelar. 3rd. New York: Informa Healthcare Publishers, 2007. 133 – 174.
- Reid, RE and RD Sindelar. Chapter 6: Pharmaceutical Biotechnology – From Nucleic Acids to Personalized Medicine. Foye’s Principles of Medicinal Chemistry. Ed. TL Lemke, DA Williams, VF Roche, and SW Zito. 6th. Philidelphia: Wolters Kluwer|Lippincott Williams & Wilkins, 2007. 115 – 174. ( previously sole author of chapter entitled: 'Pharmaceutical Biotechnology' in 5th. 2001, and 4th. 1995 editions.
- Crommelin, DJA and R D Sindelar, ed. Pharmaceutical biotechnology. 2nd. Philadelphia: Taylor & Francis, 2002.
- Sindelar, R D. 'Chapter 6: Genomics, Proteomics, and Additional Biotechnology-Related Techniques'. Pharmaceutical Biotechnology, An Introduction for Pharmacists and Pharmaceutical Scientists. Ed. DJA Crommelin and R D Sindelar. 2nd. Philadelphia: Taylor & Francis, 2002. 133 - 172.
- Evens, RP and R D Sindelar. 'Chapter 20: Biotech Products in the Pipeline'. Pharmaceutical Biotechnology, An Introduction for Pharmacists and Pharmaceutical Scientists. Ed. DJA Crommelin and R D Sindelar. 2nd. Philadelphia: Taylor & Francis, 2002. 389 - 406.
|
